RxDoctor Payments Data

Jennifer Mowry-Fisk, MD

Family Medicine · Chillicothe, OHNPI 1528086758

Payments from drug & device makers

$9,520in general payments, 2019–2025

Across 650 payments — averaging $14.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$1K
  • Pfizer$676
  • Lilly USA, LLC$618
  • AstraZeneca$524
  • Amgen$411
  • plus $4K from 39 others

What the payments were for

  • Food & beverage$9,22697%
  • Education$2653%
  • Entertainment$290%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,520 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$98,030
Medicare patients
207
Services billed
3,169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide186$210,345
JardianceEmpagliflozin104$117,391
EliquisApixaban141$109,803
TrulicityDulaglutide54$94,712
XareltoRivaroxaban50$48,726
Spiriva RespimatTiotropium Bromide27$22,681
MyrbetriqMirabegron27$17,492
Nurtec OdtRimegepant Sulfate19$17,442
Tresiba Flextouch U-100Insulin Degludec15$15,913
FarxigaDapagliflozin Propanediol23$15,331
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$14,843
JanuviaSitagliptin Phosphate12$13,101
Advair HfaFluticasone Propion/Salmeterol28$7,268
Breo ElliptaFluticasone/Vilanterol11$6,845
SymbicortBudesonide/Formoterol Fumarate22$6,237

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,781$210,345186 claims
Boehringer IngelheimJardiance, Spiriva Respimat$313$140,073131 claims
PfizerEliquis, Nurtec Odt$676$127,245160 claims
Lilly USA, LLCTrulicity$618$94,71254 claims
Johnson & JohnsonXarelto$201$48,72650 claims
GSKTrelegy Ellipta, Breo Ellipta$122$21,68927 claims
AstraZenecaFarxiga, Symbicort$524$21,56845 claims
Astellas Pharma US IncMyrbetriq$369$17,49227 claims
MerckJanuvia$302$13,10112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Chillicothe

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →